TLDR
- JNJ hit an all-time high of $264.98, with the stock now trading around $268.69, up 3.70% on the day
- The stock has delivered a 71% total return over the past year
- Guggenheim raised its price target to $270 and maintained a Buy rating, expecting Q2 revenue of $25.48 billion
- J&J raised its quarterly dividend to $1.34 per share, up from $1.30, marking 55 consecutive years of dividend increases
- Institutional buying has been heavy, with Vanguard, State Street, and Norges Bank all adding or establishing positions
Johnson & Johnson hit a fresh all-time high on Tuesday, touching $264.98 before pushing further to $268.69 — a gain of 3.70% on the day. The move puts JNJ’s market cap at roughly $646.8 billion.
The stock is up 71% over the past twelve months, with a twelve-month low of $154.21 now firmly in the rearview mirror.
At current levels, JNJ trades at a P/E ratio of 31.02 and a P/E/G of 2.58. The stock’s fifty-day moving average sits at $233.72, and the two-hundred-day at $231.37 — both well below where the stock is now.
Trading volume on Tuesday came in at 1.79 million, well below the average of 8.41 million. That kind of low-volume grind higher is sometimes a sign of steady accumulation rather than a frenzied spike.
Analyst Targets Getting Tested
Guggenheim recently raised its price target to $270, maintaining a Buy rating. The firm expects J&J to post Q2 revenue of $25.48 billion and EPS of $2.87.
Leerink upgraded the stock from Market Perform to Outperform back in May, setting a $265 price target — a level JNJ has now cleared. Wells Fargo rates it Overweight with a $263 target.
The consensus across 27 analysts is a “Moderate Buy” with a mean price target of $257.13. With the stock trading above that level, the bulls are running ahead of the Street.
Bank of America and Barclays both carry neutral/equal weight ratings, with targets of $254 and $255 respectively.
Dividend and Earnings
J&J’s most recent quarterly earnings, reported April 14, showed EPS of $2.70, beating the consensus of $2.68. Revenue came in at $24.06 billion against estimates of $23.60 billion — a 9.9% year-over-year increase.
The company also raised its quarterly dividend to $1.34 from $1.30, paid out on June 9. That puts the annualized dividend at $5.36, with a current yield of around 2.0%.
J&J has now raised its dividend for 55 consecutive years, keeping it firmly in Dividend King territory. The payout ratio sits at 61.97%.
FY2026 EPS guidance is set at $11.45–$11.65, with analysts forecasting $11.57.
Institutional Buying and Insider Activity
Institutional investors hold 69.55% of JNJ. Vanguard added 3.73 million in Q4, bringing its total to 240.35 million. State Street added 1.66 million to hold 133.87 million. Norges Bank established a new position worth roughly $6.92 billion.
Moran Wealth Management increased its stake by 15.4% in Q1, buying 12,160 additional units to hold 90,903, valued at $22.2 million.
On the insider side, EVP Kathryn Wengel sold 10,000 units at $241.15 on June 11, reducing her position by 8.05%. She still holds 114,288 units valued at roughly $27.6 million.
J&J also announced a $1 billion-plus investment in its Jacksonville, Florida operations to expand manufacturing for its Vision business, including increased capacity for ACUVUE contact lenses.
New data on IMAAVY (nipocalimab-aahu) for myasthenia gravis was presented across 12 abstracts at the European Academy of Neurology 2026 Congress.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
